Latest filing published 05 Mar 2026 for Indivior Pharmaceuticals, Inc., €985k.
No signal scores available.
Jeffrey W. Burris is a declared insider of Indivior Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 10 February 2026 to 3 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 5 March 2026, reports a share grant of €985k in Indivior Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations